Flaxseed lignans alleviates isoproterenol-induced cardiac hypertrophy by regulating myocardial remodeling and oxidative stress

References

• Yuan J, Hong H, Zhang Y, et al. Chrysophanol attenuated isoproterenol-induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway. Cell Biol Int. 2019;43(6):695–705. doi:10.1002/cbin.11146.
   PubMed Web of Science ®Google Scholar
• Doss VA, Kuberapandian D. Evaluation of anti-hypertrophic potential of Enicostemma littorale Blume on isoproterenol induced cardiac hypertrophy. Indian J Clin Biochem. 2021;36(1):33–42. doi:10.1007/s12291-019-0814-x.
   PubMed Web of Science ®Google Scholar
• Zampieri M, Berteotti M, Ferrantini C, et al. Pathophysiology and treatment of hypertrophic cardiomyopathy: new perspectives. Curr Heart Fail Rep. 2021;18(4):169–179. doi:10.1007/s11897-021-00523-0.
   PubMed Web of Science ®Google Scholar
• Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381(9862):242–255. doi:10.1016/S0140-6736(12)60397-3.
   PubMed Web of Science ®Google Scholar
• Soni RP, Katoch M, Kumar A, Verma P. Flaxseed—Composition and its healthbenefits. Res.Environ.LifeSci. 2016;9:310–316. doi:10.13140/RG.2.235208.93448.
   Google Scholar
• Ebrahimi B, Nazmara Z, Hassanzadeh N, et al. Biomedical features of flaxseed against different pathologic situations: a narrative review. Iran J Basic Med Sci. 2021;24:551. doi:10.22038/ijbms.2021.49821.11378.
   PubMed Web of Science ®Google Scholar
• Rodríguez-García C, Sánchez-Quesada C, Toledo E, Delgado-Rodríguez M, Gaforio JJ. Naturally lignan-rich foods: a dietary tool for health promotion? Molecules. 2019;24(5):917. doi:10.3390/molecules24050917.
   PubMed Web of Science ®Google Scholar
• Bowers LW, Lineberger CG, Ford NA, et al. The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth. Breast Cancer Res Treat. 2019;173(3):545–557. doi:10.1007/s10549-018-5021-6.
   PubMed Web of Science ®Google Scholar
• De Silva SF, Alcorn J. Flaxseed lignans as important dietary polyphenols for cancer prevention and treatment: chemistry, pharmacokinetics, and molecular targets. Pharmaceuticals. 2019;12(2):68. doi:10.3390/ph12020068.
   Web of Science ®Google Scholar
• Wu Y, Wang H, Wang Y, et al. Comparison of lignans and phenolic acids in different varieties of germinated flaxseed (Linum usitatissimum L.). Int J Food Sci. 2021;56(1):196–204. doi:10.1111/ijfs.14619.
   Web of Science ®Google Scholar
• Pietrofesa RA, Solomides CC, Christofidou-Solomidou M. Flaxseed mitigates acute oxidative lung damage in a mouse model of repeated radiation and hyperoxia exposure associated with space exploration. Int J Respir Pulm Med. 2014;4. DOI:10.4172/2161-105X.1000215
   Google Scholar
• Parikh M, Pierce GN. Dietary flaxseed: what we know and don’t know about its effects on cardiovascular disease. Can J Physiol Pharmacol. 2019;97(2):75–81. doi:10.1139/cjpp-2018-0547.
   PubMed Web of Science ®Google Scholar
• Chen J, Chen Y, Ye X. Lignans in diets. Handbook of Dietary Phytochem. 2019:1–22.
   Google Scholar
• Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):1–16. doi:10.1186/s13293-017-0152-8.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Seeland U. Sex and gender differences in myocardial hypertrophy and heart failure. Wien Med Wochenschr. 2011;161(5–6):109–116. doi:10.1007/s10354-011-0892-8.
   PubMedGoogle Scholar
• Khatua TN, Dinda AK, Putcha UK, Banerjee SK. Diallyl disulfide ameliorates isoproterenol induced cardiac hypertrophy activating mitochondrial biogenesis via eNOS-Nrf2-Tfam pathway in rats. Biochem Biophys Rep. 2016;5:77–88. doi:10.1016/j.bbrep.2015.11.008.
   PubMedGoogle Scholar
• Li J, Gao Q, Wang S, et al. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats. J Pharmacol Sci. 2020;144(1):30–42. doi:10.1016/j.jphs.2020.07.001.
   PubMed Web of Science ®Google Scholar
• Mahmoud YI. Kiwi fruit (Actinidia deliciosa) ameliorates gentamicin-induced nephrotoxicity in albino mice via the activation of Nrf2 and the inhibition of NF-κB. Biomed Pharmacother. 2017;94:206–218. doi:10.1016/j.biopha.2017.07.079.
   PubMed Web of Science ®Google Scholar
• Gan M, Zheng T, Shen L, et al. Genistein reverses isoproterenol-induced cardiac hypertrophy by regulating miR-451/TIMP2. Biomed Pharmacother. 2019;112:108618. doi:10.1016/j.biopha.2019.108618.
   PubMed Web of Science ®Google Scholar
• Nalban N, Sangaraju R, Alavala S, Mir SM, Jerald MK, Sistla R. Arbutin attenuates isoproterenol-induced cardiac hypertrophy by inhibiting TLR-4/NF-κB pathway in mice. Cardiovasc Toxicol. 2020;20(3):235–248. doi:10.1007/s12012-019-09548-3.
   PubMed Web of Science ®Google Scholar
• Shaikh F, Bhatt LK. Cardioprotective effect of Polymyxin-B and Dantrolene combination on isoproterenol-induced hypertrophic cardiomyopathy in rats, via attenuation of Calmodulin-dependent protein kinase II. Chem Bio. 2022;19(10). doi:10.1002/cbdv.202200309.
   Google Scholar
• Chen Y, Beng H, Su H, et al. Isosteviol prevents the development of isoprenaline-induced myocardial hypertrophy. Int J Mol Med. 2019;44(5):1932–1942. doi:10.3892/ijmm.2019.4342.
   PubMed Web of Science ®Google Scholar
• Wahid M, Saqib F, Chicea L, et al. Metabolomics analysis delineates the therapeutic effects of hydroethanolic extract of Cucumis sativus L. seeds on hypertension and isoproterenol-induced myocardial infarction. Biomed Pharmacother. 2022;148:112704. doi:10.1016/j.biopha.2022.112704.
   PubMed Web of Science ®Google Scholar
• Al-rasheed NM, Al-Oteibi MM, Al-Manee RZ, et al. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway. Drug Des Devel Ther. 2015;9:3217. doi:10.2147/DDDT.S86431.
   PubMed Web of Science ®Google Scholar
• Yoonesi AA, Sarchahi Z, Lakziyan N, Marghzar AAJ, Lakziyan R. Unsuccessful treatment the end stage of hypertrophic cardiomyopathy with cardiac resynchronization therapy: a case report. Inter J Sur Open. 2022;43:100479. doi:10.1016/j.ijso.2022.100479.
   Web of Science ®Google Scholar
• Zuo Z, Ji MY, Zhao K, et al. CD47 deficiency attenuates isoproterenol-induced cardiac remodeling in mice. Oxid Med Cell Longev. 2019;2019:1–14. doi:10.1155/2019/7121763.
   Web of Science ®Google Scholar
• Dizaji NM, Garjani A, Mousavi S, Mohammadi M, Vaez H. Time-dependent influence of infliximab on hemodynamic responses and cardiac injuries of isoproterenol-induced myocardial infarction in rats. Eur J Pharmacol. 2021;903:174122. doi:10.1016/j.ejphar.2021.174122.
   PubMed Web of Science ®Google Scholar
• Saranya S, Baskaran R, Poornima P, Vijaya Padma V. Berbamine ameliorates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and apoptosis in rats. J Cell Biochem. 2019;120(3):3101–3113. doi:10.1002/jcb.27522.
   PubMed Web of Science ®Google Scholar
• Pietrofesa RA, Velalopoulou A, Arguiri E, et al. Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice. Carcinogenesis. 2016;37(2):177–187. doi:10.1093/carcin/bgv174.
   PubMed Web of Science ®Google Scholar
• Pilar B, Güllich A, Oliveira P, Ströher D, Piccoli J, Manfredini V. Protective role of flaxseed oil and flaxseed lignan secoisolariciresinol diglucoside against oxidative stress in rats with metabolic syndrome. J Food Sci. 2017;82(12):3029–3036. doi:10.1111/1750-3841.13964.
   PubMed Web of Science ®Google Scholar